絞り込み

16646

広告

「"DeBattista C "[Author]」の検索結果

72件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial.

Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial.

Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression.

Response to: Goldberg et al. and Severance et al. letters to the editor the clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapies.

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.

Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.

Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.

2018 American Society of Consultant Pharmacists Annual Meeting & Exhibition.

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.

Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial.

Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.

Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.

Frontal and rostral anterior cingulate (rACC) theta EEG in depression: Implications for treatment outcome?

ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.

Cognitive and emotional biomarkers of melancholic depression: An iSPOT-D report.

The International Study to Predict Optimized Treatment in Depression (iSPOT-D): Outcomes from the acute phase of antidepressant treatment.

Impairment and distress patterns distinguishing the melancholic depression subtype: An iSPOT-D report.

ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.

  1. 1
  2. 2
  3. 3
  4. 4
Sort by
※並べ替えは表示に時間がかかります